NextPlat (NASDAQ:NXPL) Shares to Reverse Split on Monday, April 13th

NextPlat Corp. (NASDAQ:NXPL) shares are set to reverse split on Monday, April 13th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, April 12th.

NextPlat Price Performance

NXPL opened at $0.54 on Thursday. NextPlat has a 12-month low of $0.34 and a 12-month high of $1.11. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The business’s fifty day simple moving average is $4.91 and its 200-day simple moving average is $6.33. The company has a market capitalization of $14.57 million, a price-to-earnings ratio of -1.23 and a beta of 1.38.

NextPlat (NASDAQ:NXPL) last issued its quarterly earnings data on Tuesday, March 31st. The company reported ($0.24) earnings per share for the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%. The company had revenue of $12.81 million for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NextPlat has a consensus rating of “Sell”.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned approximately 2.31% of NextPlat at the end of the most recent reporting period. Institutional investors and hedge funds own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.